half a million women a year develop cervical cancer and half of those die as a result.
In June 2006, Merck’s Gardasil received approval from the US Food and Drug Administration and, shortly afterwards, was provisionally recommended by the US Advisory Committee on Immunization Practices for girls and women aged nine to 26.
Although the vaccine is approved for women up to the age of 26, it is generally considered to be best administered at the age of nine to 13 years, before girls become sexually active and potentially exposed to HPV.
For countries where schools are well attended by girls, a school-based vaccination programme can be the answer.
read more *www.who.int/bulletin/volumes/85/2/07-020207/en/index.html
In June 2006, Merck’s Gardasil received approval from the US Food and Drug Administration and, shortly afterwards, was provisionally recommended by the US Advisory Committee on Immunization Practices for girls and women aged nine to 26.
Although the vaccine is approved for women up to the age of 26, it is generally considered to be best administered at the age of nine to 13 years, before girls become sexually active and potentially exposed to HPV.
For countries where schools are well attended by girls, a school-based vaccination programme can be the answer.
read more *www.who.int/bulletin/volumes/85/2/07-020207/en/index.html
